SCHEMBL7805846

SCHEMBL7805846

CC(=O)Nc1ccc(-c2nc3c(s2)C(=O)c2ccccc2C3=O)o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 8/20 0.48
▸ TDO2 P48775 6/20 0.48
▸ KDM4E B2RXH2 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAOA P21397 2/20 0.37
▸ HSP90AA1 P07900 2/20 0.37
▸ HSP90AB1 P08238 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811891 0.80 IDO1 (0.55) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7811740 0.78 IDO1 (0.45) IDO1TDO2KDM4EALDH1A1SMN1; SMN2
SCHEMBL7812948 0.78 IDO1 (0.52) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7814769 0.77 IDO1 (0.55) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7813124 0.77 IDO1 (0.55) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7808342 0.77 IDO1 (0.55) IDO1TDO2ALDH1A1MAPTSMN1; SMN2
SCHEMBL7811413 0.73 IDO1 (0.50) IDO1TDO2NPC1RAB9APOLB
SCHEMBL7811377 0.73 IDO1 (0.52) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7816639 0.71 IDO1 (0.57) IDO1TDO2KDM4EALDH1A1MAPT
SCHEMBL7807731 0.70 IDO1 (0.52) IDO1TDO2ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
Send feedback